Medicine and Dentistry
Accuracy
19%
Adult
24%
Allergen
33%
Allergic Asthma
29%
Allergic Disease
43%
Allergic Response
24%
Allergic Rhinitis
29%
Allergy
70%
Amoxicillin
13%
Asthma
80%
Atopic Dermatitis
20%
Biological Product
99%
Chemotherapeutic Agent
19%
Child
86%
Chronic Rhinosinusitis
15%
Chronic Urticaria
27%
Clinical Immunology
24%
COVID-19
24%
Development
18%
Diagnosis
51%
Diseases
38%
Drug
19%
Dupilumab
42%
Emergency Department
17%
Endometriosis
24%
Food Allergy
34%
Immune Response
17%
Immunoglobulin E
37%
Immunology
37%
Introspection
16%
Lesion
13%
Mepolizumab
18%
Nasal Polyp
13%
Omalizumab
54%
Pandemic
13%
Pathogenesis
14%
Patient
74%
Pediatrics
29%
Peritoneal Fluid
15%
Phenotype
20%
Position
37%
Quality of Life
13%
Randomized Controlled Trial
16%
Reslizumab
18%
Serositis
31%
Severe Asthma
36%
Systematic Review
61%
Therapeutic Procedure
100%
Vaccine
25%
Wheeze
24%
Immunology and Microbiology
Accuracy
31%
Allergen
42%
Allergen Immunotherapy
16%
Allergic Asthma
21%
Allergy
77%
Anaphylaxis
21%
Asthma
65%
Atopic Dermatitis
36%
Biological Product
49%
Cell Maturation
12%
Cells
15%
Clinical Immunology
39%
Comprehension
17%
Coronavirinae
12%
COVID-19
60%
Cross-Reactivity
12%
Dendritic Cell
12%
Development
68%
Dupilumab
12%
Electric Potential
14%
Food Allergy
63%
Gene
18%
Hypersensitive Response
25%
Immune Response
11%
Immunity
23%
Immunocompetent Cell
13%
Immunoglobulin E
41%
Immunology
36%
Immunomodulating Drugs
12%
Immunoregulation
18%
Interferon Type I
24%
Interleukin Derivative
24%
Interleukin-33
12%
Interleukin-38
12%
Microbiome
16%
Microorganism
12%
Mouse Model
12%
Phenotype
16%
Position
25%
Pregnancy
12%
Protein Binding
12%
Regulatory Mechanism
11%
Severe Acute Respiratory Syndrome Coronavirus 2
29%
Skin
19%
Th2 Cell
12%
Thrombocyte Activating Factor
12%
Time
14%
Tissues
13%
Tumor Necrosis Factor
13%
Vaccine Efficacy
34%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
23%
Allergen
42%
Allergic Asthma
12%
Allergic Disease
25%
Allergic Reaction
37%
Allergy
32%
Amoxicillin
13%
Anaphylaxis
8%
Antibiotics
8%
Antioxidant
12%
Asthma
43%
Atopy
12%
Benralizumab
24%
Biological Product
86%
Cephalosporin
12%
Chronic Rhinosinusitis
13%
Chronic Urticaria
29%
Coronavirinae
12%
Corticosteroid
8%
Diseases
28%
Drug
15%
Dupilumab
20%
Food Allergy
36%
Immunoglobulin E
36%
Immunomodulating Agent
12%
Immunotherapy
24%
Incidence
9%
Initiation Factor 2
12%
Insulin Resistance
15%
Lactam
12%
Mepolizumab
8%
Mortality Rate
24%
Nose Polyp
13%
Nuclear Factor
9%
Nut Allergy
12%
Omalizumab
57%
Pandemic
12%
Peanut
44%
Peanut Allergy
26%
Peroxisome Proliferator Activated Receptor
12%
Placebo
12%
Randomized Controlled Trial
8%
Rash
12%
Reslizumab
8%
SARS Coronavirus
15%
Serum Sickness
12%
Sulforaphane
9%
Symptom
7%
Tree
16%
Vaccine
24%
